Reshma Kewalramani
Fortune : 21 M $ au 31/05/2026
Fortune : 21 M $ au 31/05/2026
Reshma Kewalramani est présidente, directrice générale et directrice de Vertex Pharmaceuticals, Inc. Auparavant, elle était vice-présidente du développement clinique mondial et de la néphrologie chez Amgen, Inc. Elle a obtenu un doctorat de la faculté de médecine de l'université de Boston.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/03/2026 | 47 800 ( 0,02 % ) | 21 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Directeur Général | 01/04/2020 |
| ALPINE IMMUNE SCIENCES, INC. | President | 20/05/2024 |
Ginkgo Bioworks, Inc.
Ginkgo Bioworks, Inc. Information Technology ServicesTechnology Services Develops biological technology and software solutions | Directeur/Membre du Conseil | 03/08/2021 |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Directeur/Membre du Conseil | - |
Biomedical Sciences Careers Program, Inc. | Directeur/Membre du Conseil | - |
Year Up, Inc.
Year Up, Inc. Miscellaneous Commercial ServicesCommercial Services Provides educational and professional development programs | Directeur/Membre du Conseil | 18/09/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
| GINKGO BIOWORKS HOLDINGS, INC. | Directeur/Membre du Conseil | 13/06/2024 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2017 |
| GINO BIOW | Directeur/Membre du Conseil | - |
| ░░░░░░ ░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 12 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Health Services |
Biomedical Sciences Careers Program, Inc. | |
Year Up, Inc.
Year Up, Inc. Miscellaneous Commercial ServicesCommercial Services Provides educational and professional development programs | Commercial Services |
Boston University School of Medicine
Boston University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ginkgo Bioworks, Inc.
Ginkgo Bioworks, Inc. Information Technology ServicesTechnology Services Develops biological technology and software solutions | Technology Services |
Alpine Immune Sciences, Inc.
Alpine Immune Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as an bio pharmaceutical company that develops immunotherapies for autoimmune and inflammatory diseases | Health Technology |
Kidney Health Initiative | |
Soaring Eagle Acquisition Corp.
Soaring Eagle Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc. Medical/Nursing ServicesHealth Services Develops biological engineering products and custom microbes | Health Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national